• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?

作者信息

Di Minno Giovanni, Coppola Antonio

机构信息

Regional Reference Centre for Coagulation Disorders, Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy.

出版信息

Blood Transfus. 2011 May;9 Suppl 2(Suppl 2):s14-20. doi: 10.2450/2011.004S.

DOI:10.2450/2011.004S
PMID:21839028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3159912/
Abstract
摘要

相似文献

1
A role for von Willebrand factor in immune tolerance induction in patients with haemophilia A and inhibitors?血管性血友病因子在甲型血友病及抑制物患者免疫耐受诱导中的作用？
Blood Transfus. 2011 May;9 Suppl 2(Suppl 2):s14-20. doi: 10.2450/2011.004S.
2
Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors.Fanhdi/Alphanate（血浆源性含血管性血友病因子的凝血因子VIII浓缩物）用于诱导A型血友病伴抑制物患者免疫耐受的临床概述
Haemophilia. 2016 Jan;22(1):e71-4. doi: 10.1111/hae.12857. Epub 2015 Nov 27.
3
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.在一项观察性免疫耐受诱导研究中，关于高危血友病A抑制物患者使用单一凝血因子VIII/血管性血友病因子浓缩物的免疫耐受的首份前瞻性报告。
Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. Epub 2015 Jul 23.
4
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A.在14例重度甲型血友病患者中使用含血管性血友病因子的凝血因子VIII浓缩剂（Haemoctin SDH®）诱导免疫耐受。
Haemophilia. 2011 Sep;17(5):e837-40. doi: 10.1111/j.1365-2516.2011.02577.x. Epub 2011 Jun 7.
5
Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.在澳大利亚患有高滴度抑制物的儿童重度甲型血友病患者中，使用含或不含免疫抑制的凝血因子 VIII/血管性血友病因子浓缩物（BIOSTATE）诱导免疫耐受：一项多中心回顾性研究。
Thromb Res. 2014 Nov;134(5):1046-51. doi: 10.1016/j.thromres.2014.09.010. Epub 2014 Sep 21.
6
The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.使用凝血因子VIII/血管性血友病因子浓缩物诱导高滴度抑制物的甲型血友病患者产生免疫耐受：临床结局与抑制物表位谱的关联
Haemophilia. 2008 Mar;14(2):295-302. doi: 10.1111/j.1365-2516.2007.01620.x. Epub 2007 Dec 12.
7
von Willebrand factor: what is its role in the immune response in haemophilia?血管性血友病因子：它在血友病免疫反应中起什么作用？
Haemophilia. 2011 Jan;17(1):e235-8. doi: 10.1111/j.1365-2516.2010.02277.x.
8
Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry.免疫耐受诱导中血浆源性因子VIII/血管性血友病因子的前瞻性观察研究：PRISM注册研究
Haemophilia. 2015 Mar;21(2):e122-e124. doi: 10.1111/hae.12590. Epub 2015 Jan 27.
9
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.在高反应不良风险的血友病A抑制物患者中，使用高纯度血管性血友病因子/ VIII复合物浓缩物诱导免疫耐受。
Haemophilia. 2007 Jul;13(4):373-9. doi: 10.1111/j.1365-2516.2007.01484.x.
10
Role of von Willebrand factor in immune tolerance induction.血管性血友病因子在免疫耐受诱导中的作用。
Blood Coagul Fibrinolysis. 2005 Apr;16 Suppl 1:S27-31. doi: 10.1097/01.mbc.0000167660.30886.e9.

引用本文的文献

1
Hemostats in the clinic.临床中的止血钳。
Bioeng Transl Med. 2024 May 1;9(6):e10673. doi: 10.1002/btm2.10673. eCollection 2024 Nov.
2
Towards personalised therapy for von Willebrand disease: a future role for recombinant products.迈向血管性血友病的个性化治疗：重组产品的未来作用。
Blood Transfus. 2016 May;14(2):262-76. doi: 10.2450/2016.0258-15. Epub 2016 Mar 22.
3
Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report.成功诱导免疫耐受：含高剂量血管性血友病因子的凝血因子VIII与静脉注射脉冲式免疫球蛋白联合应用的病例报告
J Med Case Rep. 2012 Oct 11;6:350. doi: 10.1186/1752-1947-6-350.

本文引用的文献

1
Plasma-derived versus recombinant Factor VIII concentrates for the treatment of haemophilia A: recombinant is better.用于治疗甲型血友病的血浆源性与重组凝血因子 VIII 浓缩剂：重组的更好。
Blood Transfus. 2010 Oct;8(4):292-6. doi: 10.2450/2010.0067-10.
2
Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better.用于治疗甲型血友病的血浆源性与重组凝血因子VIII浓缩剂：血浆源性的更好。
Blood Transfus. 2010 Oct;8(4):288-91. doi: 10.2450/2010.0072-10.
3
Von Willebrand factor-containing factor VIII concentrates and inhibitors in haemophilia A. A critical literature review.含血管性血友病因子的因子 VIII 浓缩物和抑制剂在血友病 A 中的作用。一项关键性文献回顾。
Thromb Haemost. 2010 Nov;104(5):931-40. doi: 10.1160/TH10-03-0151. Epub 2010 Sep 13.
4
Clinical issues in inhibitors.抑制剂的临床问题。
Haemophilia. 2010 Jul;16 Suppl 5:54-60. doi: 10.1111/j.1365-2516.2010.02294.x.
5
Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence-based approaches.优化重型 A 型血友病伴抑制物患者的免疫耐受诱导管理：迈向循证方法。
Br J Haematol. 2010 Sep;150(5):515-28. doi: 10.1111/j.1365-2141.2010.08263.x. Epub 2010 Jun 22.
6
Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A.血友病 A 患者免疫耐受诱导期间因子 VIII 抑制剂的特异性。
Haemophilia. 2010 Nov;16(6):892-901. doi: 10.1111/j.1365-2516.2010.02272.x.
7
Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.了解血友病 A 抑制剂的发展：走向临床预测和预防策略。
Haemophilia. 2010 Jan;16 Suppl 1:13-9. doi: 10.1111/j.1365-2516.2009.02175.x.
8
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.VIII 因子基因（F8）突变作为高反应性抑制物血友病 A 患者免疫耐受诱导结局的预测因子。
J Thromb Haemost. 2009 Nov;7(11):1809-15. doi: 10.1111/j.1538-7836.2009.03615.x. Epub 2009 Sep 9.
9
The molecular mechanisms of immunomodulation and tolerance induction to factor VIII.VIII 因子免疫调节和诱导耐受的分子机制。
J Thromb Haemost. 2009 Sep;7(9):1446-56. doi: 10.1111/j.1538-7836.2009.03538.x. Epub 2009 Jul 6.
10
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.重组和血浆源性凝血因子VIII产品在甲型血友病小鼠中诱导出不同的脾脏细胞因子微环境。
Blood. 2009 Jul 23;114(4):871-80. doi: 10.1182/blood-2008-09-174649. Epub 2009 May 1.